Ehave at the forefront of Canada’s medical cannabis transformation


These new partnerships and takeovers have culminated in a wealth of opportunities for small cap investors around the world.

Of the many new partnerships in this space, perhaps the most promising is the partnership between one of Canada’s cannabis giants, MedReleaf (NASDAQOTH:MEDFF) and Ehave (OTC: EHVVF), a smaller publicly traded medical technology company which has introduced a platform to address the biggest problem facing the Canadian cannabis industry.

Medical marijuana is becoming an increasingly accepted form of treatment among North American medical professionals – when surveyed by the Journal of the American Board of Family Medicine, 92% of family physicians stated that they believe that continuing medical marijuana education should be available to family physicians. However, despite the growing acceptance of marijuana and its impending legalization, many medical professionals have been hesitant to discuss marijuana as an alternative to prescription drugs because they lack the necessary knowledge to recommend it to their patients.